Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Lactose operon repressor (LacI) is a well-characterized transcription factor from Escherichia coli that serves as the fundamental model for understanding gene regulation and allosteric control [1, 3, 12]. It functions by binding to specific operator DNA sequences to block the expression of genes involved in lactose utilization when the sugar is absent. In the presence of lactose-derived inducers like allolactose, the repressor undergoes a conformational change that causes it to dissociate from the DNA, thereby permitting gene transcription [1, 9, 13]. While not a direct therapeutic target for treating human disease, LacI is a critical tool in biotechnology and synthetic biology [3, 11]. It is widely used to create inducible gene expression systems in both prokaryotic and eukaryotic cells, facilitating the large-scale production of recombinant proteins and the development of sophisticated gene circuits for advanced therapies such as CAR-T cell engineering [6, 7, 11, 13].
The LacI repressor functions as a homotetramer that binds to the operator DNA sequence (lacO) of the lactose operon, physically occluding RNA polymerase and inhibiting the transcription of genes required for lactose metabolism [1, 12, 13]. When an inducer molecule, such as the natural metabolite allolactose or the synthetic analog IPTG, binds to the core regulatory domain of LacI, it triggers an allosteric conformational change that significantly reduces the protein's affinity for the operator DNA. This dissociation allows RNA polymerase to access the promoter and initiate transcription of the operon [1, 9, 13].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactose operon repressor (LacI) (LacI).